INCY vs SRBK · P/E 14, rev $5.14B vs P/E 33, rev $46.3M
Incyte Corporation (INCY) versus SR Bancorp, Inc. Common stock (SRBK) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
SR Bancorp, Inc. Common stock (SRBK) is a banks - regional company listed on NASDAQ.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported SRBK revenue for 2025-06-30 was $46.3M. Net income was $5.1M. Revenue was up 13.3% from 2024-06-30 to 2025-06-30. SRBK currently screens at market cap $140.4M and trailing P/E 32.6.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. SRBK currently screens at market cap $140.4M and trailing P/E 32.6.
Not investment advice. Open the INCY and SRBK stock pages for the full models.
Not investment advice.